<DOC>
	<DOCNO>NCT00453687</DOCNO>
	<brief_summary>This study investigate safety tolerability inhale dos GSK233705 new formulation .</brief_summary>
	<brief_title>A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers .</brief_title>
	<detailed_description>A single-centre , randomize , double-blind placebo-controlled , dose-ascending , cross-over study evaluate safety , tolerability , pharmacodynamics pharmacokinetics single inhaled dos GSK233705 ( 50 , 100 200Âµg ) , formulate excipient magnesium stearate , healthy volunteer .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy male subject 1855 year old NonSmokers Any subject breathing problem . High blood pressure heart abnormality . Any subject currently take prescription nonprescription medication .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>GSK233705 ,</keyword>
	<keyword>Magnesium Stearate ,</keyword>
</DOC>